Skip to main content
. 2013 Nov 29;8(11):e81967. doi: 10.1371/journal.pone.0081967

Table 3. Meta-analysis of miR-499 and miR-149 with gastrointestinal cancer susceptibility.

MiR-499 GG vs AA AG vs AA G vs A GG+AG vs AA GGvs AG+AA
N OR (95%CI) Ph OR (95%CI) Ph OR (95%CI) Ph OR (95%CI) Ph OR (95%CI) Ph
Total 11 1.33(0.96,1.85) 0.03 1.02(0.85,1.21) 0.006 1.13(0.96,1.33) <0.0001 1.08(0.90,1.30) 0.001 1.34(0.99,1.80) 0.04
Cancer type
HCC 4 1.27(0.60,2.69) 0.04 0.99(0.78,1.26) 0.16 1.12(0.77,1.62) 0.004 1.09(0.73,1.64) 0.02 1.26(0.92,1.73) 0.11
GC 2 1.28(0.85,1.93) 0.42 0.92(0.76,1.11) 0.48 1.01(0.87,1.18) 0.22 0.96(0.80,1.15) 0.31 1.31(0.87,1.96) 0.47
CRC 2 1.66(1.02,2.70) 0.12 0.94(0.74,1.20) 0.10 1.14(0.94,1.37) 0.16 1.05(0.83,1.31) 0.96 1.64(0.61,4.43) 0.05
Others 3 1.39(0.51,3.78) 0.02 1.21(0.74,1.97) 0.007 1.25(0.75,2.00) 0.0001 1.23(0.72,2.11) 0.0005 1.33(0.55,3.21) 0.04
Ethnicity
Caucasian 2 1.59(0.79,3.16) 0.09 0.80(0.56,1.14) 0.26 1.20(0.97,1.48) 0.29 1.05(0.76,1.43) 0.95 1.69(0.76,3.78) 0.03
Asian 9 1.26(0.84,1.89) 0.03 1.06(0.87,1.28) 0.006 1.11(0.91,1.35) <0.0001 1.09(0.88,1.35) 0.0003 1.27(0.99,1.63) 0.10
MiR-149 TT vs CC TC vs CC T vs C TT+TC vs CC TT vs TC+CC
N OR (95%CI) Ph OR (95%CI) Ph OR (95%CI) Ph OR (95%CI) Ph OR (95%CI) Ph
Total 7 1.02(0.84,1.24) 0.79 0.83(0.69,1.00) 0.99 1.06(0.97,1.16) 0.81 0.92(0.77,1.10) 0.98 1.15(1.03,1.30) 0.68
Cancer type
CRC 3 1.07(0.81,1.42) 0.62 0.86(0.66,1.11) 1.00 1.06(0.94,1.21) 0.98 0.94(0.74,1.20) 0.99 1.16(0.97,1.38) 0.63
GC 2 0.99(0.70,1.40) 0.98 0.79(0.56,1.12) 0.63 1.07(0.92,1.25) 0.88 0.89(0.64,1.24) 0.79 1.18(0.96,1.45) 0.61
Others 2 0.95(0.62,1.46) 0.17 0.82(0.52,1.30) 0.54 1.07(0.76,1.51) 0.09 0.90(0.59,1.36) 0.31 1.11(0.87,1.42) 0.10
Ethnicity
Asian 6 0.99(0.81,1.21) 0.85 0.83(0.67,1.02) 0.98 1.06(0.97,1.16) 0.71 0.91(0.75,1.11) 0.95 1.14(1.01,1.29) 0.69

P h: P value of Q-test for heterogeneity test.Random-effects model was used when a P value<0.10 for heterogeneity test; otherwise, fixed-effects model was used.